Leukemia stem cells (LSCs) in AML were the first identified cancer stem-cell population, which were shown to be enriched in the CD34 + CD38- fraction of whole blasts, as measured by the ability to engraft in the bone marrow of immunodeficient mice [39,40]. The gene discussed is CD38; the disease is acute myeloid leukemia.